ARG42658

anti-QPCT antibody

anti-QPCT antibody for ICC/IF and Human

Overview

Product Description Rabbit Polyclonal antibody recognizes QPCT
Tested Reactivity Hu
Tested Application ICC/IF
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name QPCT
Antigen Species Human
Immunogen Recombinant fusion protein corresponding to aa. 1-361 of Human QPCT (NP_036545.1).
Conjugation Un-conjugated
Alternate Names EC 2.3.2.5; Glutaminyl cyclase; Glutamyl cyclase; EC; QC; Glutaminyl-peptide cyclotransferase; GCT; sQC; Glutaminyl-tRNA cyclotransferase

Application Instructions

Application Suggestion
Tested Application Dilution
ICC/IF1:50 - 1:100
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Affinity purified.
Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 25797 Human QPCT

Swiss-port # Q16769 Human Glutaminyl-peptide cyclotransferase

Gene Symbol QPCT
Gene Full Name glutaminyl-peptide cyclotransferase
Background This gene encodes human pituitary glutaminyl cyclase, which is responsible for the presence of pyroglutamyl residues in many neuroendocrine peptides. The amino acid sequence of this enzyme is 86% identical to that of bovine glutaminyl cyclase. [provided by RefSeq, Jul 2008]
Function Responsible for the biosynthesis of pyroglutamyl peptides. Has a bias against acidic and tryptophan residues adjacent to the N-terminal glutaminyl residue and a lack of importance of chain length after the second residue. Also catalyzes N-terminal pyroglutamate formation. In vitro, catalyzes pyroglutamate formation of N-terminally truncated form of APP amyloid-beta peptides [Glu-3]-amyloid-beta. May be involved in the N-terminal pyroglutamate formation of several amyloid-related plaque-forming peptides. [UniProt]
Cellular Localization Secreted. [UniProt]
Calculated MW 41 kDa